<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04193774</url>
  </required_header>
  <id_info>
    <org_study_id>S62672</org_study_id>
    <nct_id>NCT04193774</nct_id>
  </id_info>
  <brief_title>Optimization of Sampling and Processing of Samples for Molecular Microbial Research on Ocular Surface Samples</brief_title>
  <acronym>EPSO</acronym>
  <official_title>Optimization of Sampling for Molecular Microbial Research on Ocular Surface Samples and Building a Framework for Comparing Current Sequencing Results Using Different Extraction Protocols.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of anesthetics and the processing of the retrieved samples are major confounding
      factors that influence the results of microbiome research.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of anesthetics is subject of discussion in ocular surface microbiome research. One
      publication showed a significant lower alpha diversity when using an anesthetic. However, the
      diluting effect of the anesthetic drop itself was not accounted for. On the other hand, using
      anesthetics will enable patients to tolerate sampling better and this might allow better
      sampling. To analyze the effect of anesthetic drops on the composition of the ocular surface
      microbiome, we sampled volunteers undergoing general anesthesia. By using artificial tears as
      a control, we aimed at accounting for the diluting effect of the anesthetic. By using
      volunteers under general anesthesia, we wanted to assure similar pressure with or without
      topical anesthesia since the executor was not influenced by the patient's reaction.

      Furthermore, the effect of different extraction protocols on sequencing results will be
      assessed by sampling different volunteers in both eyes on non consecutive days.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 19, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>When the patient is under general anesthesia for another reason, he or she receives a drop of artificial tears in one eye and a drop of anesthetic in the other eye in a randomized way.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
    <masking_description>The nurse application the drops receives a closed envelope wherein the information about which eye receives what type of drop is included. The executor is blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in richness and evenness of distribution of the microbial flora measured as operational taxonomic units</measure>
    <time_frame>5 minutes per sampling session</time_frame>
    <description>The difference in richness and evenness of distribution of the microbial flora of samples retrieved after a drop of topical anesthesia versus samples retrieved after a drop of artificial tears.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in richness and evenness of distribution of the microbial flora measured as operational taxonomic units</measure>
    <time_frame>5 minutes per sampling session</time_frame>
    <description>The effect of the different microbial DNA extraction protocols on the richness and evenness of distribution of the microbial flora of the ocular surface will be compared.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Microbiota</condition>
  <condition>Ocular Surface</condition>
  <arm_group>
    <arm_group_label>Drop of artificial tears</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Drop op anesthetic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Conjunctival swab</intervention_name>
    <description>Swab of the conjunctival fornices of both eyes</description>
    <arm_group_label>Drop of artificial tears</arm_group_label>
    <arm_group_label>Drop op anesthetic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxybuprocaine Hydrochloride 0.4% Eye Drops</intervention_name>
    <description>One drop of topical anesthesia in one eye</description>
    <arm_group_label>Drop op anesthetic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>artificial tears</intervention_name>
    <description>One drop of artificial tears in the other eye</description>
    <arm_group_label>Drop of artificial tears</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing to undergo sampling of the conjunctiva

          -  Fluent in written and verbal Dutch

          -  Capable of giving informed consent

        Exclusion Criteria:

          -  Allergy to oxybuprocaine

          -  Medication usage in one eye only
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heleen Delbeke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heleen Delbeke, MD</last_name>
    <phone>003216346228</phone>
    <email>heleen.delbeke@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospitals Leuven, Department of Ophthalmology</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heleen Delbeke, MD</last_name>
      <email>heleen.delbeke@uzleuven.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 4, 2019</study_first_submitted>
  <study_first_submitted_qc>December 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>December 6, 2019</last_update_submitted>
  <last_update_submitted_qc>December 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ocular surface microbiome</keyword>
  <keyword>Anesthesia</keyword>
  <keyword>Extraction protocol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Benoxinate</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Lubricant Eye Drops</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

